p-value Group has been acquired by Publicis Groupe
p-value Group, one of the largest independent medical communications agencies in North America, has been acquired by Publicis Groupe (ENXTPA:PUB) for its strong strategic fit, global scale and cultural alignment. The acquisition enhances Publicis Groupe’s medical communications capabilities in the USA and supports its broader strategy of integrating science-first solutions across its global network.
Founded in 2004 by Linda Corvari, p-value is a leading full-service provider of medical and scientific communications, serving marquee clients across the life sciences sector. The company specializes in medical strategy, scientific communications, content development and speaker bureau management, earning a strong reputation for scientific rigor, exceptional client service and a culture of excellence. p-value maintains diverse and expanding expertise across therapeutic areas, with particularly strong experience in dermatology.
Publicis Groupe, founded in 1926 and headquartered in Paris, France, is the world's second-largest advertising holding company by revenue. The group offers a broad range of services, including traditional and digital advertising, public relations and consulting. It employs approximately 108,000 people worldwide, with over 80% of its revenue generated from developed markets, particularly North America and Europe.
Oaklins Intrepid in Los Angeles acted as the exclusive sell-side advisor in this transaction, highlighting the team’s deep domain expertise in the pharmaceutical services sector and broader marketing agency landscape.
Contacter l'équipe de la transaction
Adam Abramowitz
Oaklins Intrepid
Greg Passani
Oaklins Intrepid
Ellie Taraska
Oaklins Intrepid
Transactions connexes
Middlecon has been acquired by Nion
Middlecon has been acquired by Nion, a digital consultancy backed by Stella Capital. The acquisition strengthens Nion’s capabilities in data management and advanced analytics, enabling it to undertake larger and more complex data-driven initiatives for its customers. The partnership with Nion provides Middlecon with a strong foundation for continued growth and expansion.
En apprendre plusBackspin has completed a mandatory public tender offer for the shares of Spindox
Backspin S.p.A. has completed a mandatory public tender offer for Spindox S.p.A.
En apprendre plusRare Patient Voice has been acquired by Konovo
Rare Patient Voice has been acquired by Konovo, a technology-first healthcare intelligence company backed by Fraser Healthcare Partners.
En apprendre plus